74 results
8-K
EX-1.1
SLNO
Soleno Therapeutics Inc
7 May 24
Soleno Therapeutics Announces Pricing of Approximately $138 Million Public Offering of Common Stock
5:28pm
, including the European Union General Data Protection Regulation (EU 2016 679), Medicare, Title XVIII of the Social Security Act, and Medicaid, Title … of the U.S. Treasury Department (“OFAC”), or by the United Nations Security Council, the European Union, Her Majesty’s Treasury-UK, or other relevant
424B5
SLNO
Soleno Therapeutics Inc
6 May 24
Prospectus supplement for primary offering
4:58pm
hyperphagia. We have a Fast-Track designation for DCCR in PWS and orphan designation for the drug in the United States (U.S.) and European Union (E.U … /1129 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018.
Any invitation or inducement to engage in investment
424B5
SLNO
Soleno Therapeutics Inc
2 May 24
Prospectus supplement for primary offering
4:04pm
have a Fast-Track designation for DCCR in PWS and orphan designation for the drug in the United States (U.S.) and European Union (E.U.).
DCCR has been … of the European Union (Withdrawal) Act 2018.
Any invitation or inducement to engage in investment activity (within the meaning of Section 21 of the FSMA
S-3ASR
3ybgpklt1kexpcux04
2 Jan 24
Automatic shelf registration
4:06pm
8-K
EX-10.1
lbgvcq
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-1.1
kkn5hvua
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
424B5
2vj0zfl35
29 Sep 23
Prospectus supplement for primary offering
4:51pm
424B5
rqf58ppxo4g64 znqhvy
27 Sep 23
Prospectus supplement for primary offering
5:26pm
8-K
EX-10.1
lkoe4y6scpas4x8 85
19 Dec 22
Soleno Therapeutics Announces Financing Commitment for up to $60 Million
4:49pm